A successful anticoagulation protocol for the first HeartMate® II implantation in the United States

Texas Heart Institute Journal

Volumn 32, Issue 3, 2005, Pages 399-401

  Amir, Offer ^a,b   Bracey, Arthur W ^a   Smart, Frank W ^a   Delgado III, Reynolds M ^a   Shah, Nyma ^a   Kar, Biswajit ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

Activated partial thromboplastin time; Anticoagulants administration and dosage; Blood coagulation tests; Cardiac surgical procedures; Heart assist devices; Human; Male; Monitoring, physiologic instrumentation; Platelet function tests; Prothrombin time

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; HEPARIN; INOTROPIC AGENT; WARFARIN;

ADULT; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; AORTA BALLOON; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CASE REPORT; COCAINE DEPENDENCE; HEART TRANSPLANTATION; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PLASMAPHERESIS; SMOKING; THROMBOCYTE COUNT; THROMBOGENESIS; UNITED STATES;

ADULT; ANTICOAGULANTS; ANTITHROMBINS; DEXTRANS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEART-ASSIST DEVICES; HIRUDINS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PEPTIDE FRAGMENTS; PROSTHESIS IMPLANTATION; RECOMBINANT PROTEINS; SHOCK, CARDIOGENIC; THROMBOEMBOLISM;

EID: 24944489350     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Goldstein DJ, Beauford RB. Left ventricular assist devices and bleeding: adding insult to injury. Ann Thorac Surg 2003; 75(6 Suppl):S42-7.
2. Reilly MP, Wiegers SE, Cucchiara AJ, O'Hara ML, Plappert TJ, Loh E, et al. Frequency, risk factors, and clinical outcomes of left ventricular assist device-associated ventricular thrombus. Am J Cardiol 2000;86:1156-9, A10.
3. Zeerleder S, Mauron T, Lammle B, Wuillemin WA. Effect of low-molecular weight dextran sulfate on coagulation and platelet function tests. Thromb Res 2002;105:441-6.
4. von Kier S, Smith A. Hemostatic product transfusions and adverse outcomes: focus on point-of-care testing to reduce transfusion need. J Cardiothorac Vase Anesth 2000;14(3 Suppl 1):15-21; discussion 37-8.
5. Fries D, Innerhofer P, Streif W, Schobersberger W, Margreiter J, Antretter H, Hormann C. Coagulation monitoring and management of anticoagulation during cardiac assist device support. Ann Thorac Surg 2003;76:1593-7.
6. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999;88:312-9.
7. Copeland JG, Arabia FA, Smith RG, Sethi GK, Nolan PE, Banchy ME. Arizona experience with CardioWest Total Artificial Heart bridge to transplantation. Ann Thorac Surg 1999;68:756-60.